Selank Research Hub
Selank is a synthetic heptapeptide analogue of the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg). It was developed in Russia and has been studied in neuropeptide and anxiolytic research contexts. This hub provides key research information for laboratory researchers working with Selank.
All Selank supplied by Precision Chain Peptides is strictly for legitimate laboratory and in-vitro research use only. Not for human or animal administration.
Compound Overview
- Full name: Thr-Lys-Pro-Arg-Pro-Gly-Pro (Selank)
- Molecular formula: C₃₃H₅₇N₁₁O₉
- Molecular weight: 751.88 g/mol
- Format supplied: Lyophilised powder
- Research purity: ≥98% (HPLC verified)
- Storage: -20°C, away from light and moisture
Research Background
Selank is a tuftsin analogue that has been studied in preclinical research examining anxiolytic-like behaviour in animal models and interactions with GABA and serotonin signalling pathways. It is classified as a neuropeptide and is studied alongside Semax, DSIP, and other compounds within neuropeptide research contexts. Published research includes animal model and in-vitro studies; it is not approved for therapeutic use in humans.
Research Articles
Related Research Category
Selank is classified within our Neuropeptide Research collection, alongside Semax and DSIP.
Supply Information
Precision Chain Peptides supplies Selank 10mg in lyophilised format, HPLC-verified with COA available on request.
View Selank 10mg — Research Peptide
Quality & Documentation
For COA requests, see our Quality & Testing page or contact us.
Research Use Only
All compounds are strictly for legitimate laboratory and in-vitro research use only. See our Research Use Only Policy.